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Recovery of hippocampal functions 
and modulation of muscarinic 
response by electroacupuncture in 
young diabetic rats
Marzia Soligo1, Sonia Piccinin2, Virginia Protto1, Francesca Gelfo3,4, Maria Egle De Stefano  5, 
Fulvio Florenzano2, Erica Berretta  3,6, Laura Petrosini3,6, Robert Nisticò2,7 & Luigi Manni  1
The muscarinic receptor response to acetylcholine regulates the hippocampal-related learning, 
memory, neural plasticity and the production and processing of the pro-nerve growth factor (proNGF) 
by hippocampal cells. The development and progression of diabetes generate a mild cognitive 
impairment reducing the functions of the septo-hippocampal cholinergic circuitry, depressing neural 
plasticity and inducing proNGF accumulation in the brain. Here we demonstrate, in a rat model of 
early type-1 diabetes, that a physical therapy, the electroacupuncture, counteracts the diabetes-
induced deleterious effects on hippocampal physiology by ameliorating hippocampal-related memory 
functions; recovering the impaired long-term potentiation at the dentate gyrus (DG-LTP) and the 
lowered expression of the vesicular glutamate transporter 1; normalizing the activity-dependent 
release of proNGF in diabetic rat hippocampus. Electroacupuncture exerted its therapeutic effects by 
regulating the expression and activity of M1- and M2-acetylcholine muscarinic receptors subtypes in 
the dentate gyrus of hippocampus. Our results suggest that a physical therapy based on repetitive 
sensory stimulation could promote hippocampal neural activity, neuronal metabolism and functions, 
and conceivably improve the diabetes-induced cognitive impairment. Our data can support the setup of 
therapeutic protocols based on a better integration between physical therapies and pharmacology for 
the cure of diabetes-associated neurodegeneration and possibly for Alzheimer’s disease.
Dysfunctions in hippocampus-related behaviour and neural plasticity characterize both Alzheimer’s dis-
ease and diabetic encephalopathy1–3 that share common hallmarks, such as accumulation of beta-amyloid, of 
hyper-phosphorylated tau4, 5 and of the pro-nerve growth factor (proNGF) in the brain6, 7. Basal forebrain cho-
linergic neurons (BFCN) in the medial septum project to the hippocampus, regulating the activity of its internal 
excitatory and inhibitory circuitries, as well as those of its external inputs8. The BFCNs activity modulates hip-
pocampal plasticity and regulates the production, secretion and processing of proNGF by hippocampal cells9, 10 
providing a sort of “on demand” supply of the pro-neurotrophin. This in turn regulates remote BFCN metabo-
lism11 but also directly influences hippocampal neurons survival12, 13, functions and plasticity14.
The pro-apoptotic or pro-neurotrophic action of proNGF depends on the balance among different possible 
receptor complexes15 and on the activity of the extracellular proteases cascade responsible for proNGF conver-
sion into the neurotrophic mature NGF (mNGF)10. We recently demonstrated a prevalence of proNGF and a 
lower mNGF/proNGF ratio, in the brain of early diabetic rats6. ProNGF is also predominant in the brain of 
Alzheimer’s patients7, indicating that it could reliably participate in the generation of neuronal sufferance and 
cognitive impairment.
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A physical therapy, the electroacupuncture (EA), based on repetitive and controlled stimulation of sensory 
afferents, regulates brain NGF content in diabetic rats5. It is known that acupuncture, as well as physical exercise, 
which shares with electroacupuncture common neurophysiological substrates16, could regulate brain activity, 
not only in pain-related brain areas17 but also in the limbic system18. Electroacupuncture positively affects hip-
pocampal neurogenesis19 and counteracts hippocampus-related cognitive deficits in diabetic rats20. Nevertheless, 
the mechanism(s) underlying these electroacupuncture effects, on hippocampal physiology, are still largely 
unexplored.
Type-1 diabetes could early affect cognitive performance in young people, generating a mild cognitive deficit 
that in turn could progress in diabetic encephalopathy2, 4, 21. Our work aimed at studying the impact of early 
type-1 diabetes and electroacupuncture on activity-regulated hippocampal functions, namely the generation of 
LTP at dentate gyrus (DG-LTP) and the release and extracellular processing of proNGF. We also explored the 
mechanistic hypothesis that electroacupuncture corrects the diabetes-induced dysregulation in DG-LTP and 
proNGF release by acting on the hippocampal muscarinic responsivity.
Results
Diabetes-induced hippocampal cell loss and decrease in nuclear size was reversed by electroac-
upuncture. We used a widely accepted animal model of type 1 diabetes22. The study design is depicted at 
Fig. 1A. We checked the establishment of diabetes by analysing blood glucose concentration and body weight 
over 4 weeks (Fig. 1B,C). Streptozotocin (STZ) increased blood glucose levels (Fig. 1B). These values persisted 
significantly high also in the STZ+EA group, suggesting that electroacupuncture did not affect the overall glucose 
metabolism. Rats’ body weight significantly decreased (Fig. 1C) in both STZ and STZ+EA groups compared to 
controls.
Diabetes induces cell loss in the hippocampus3. We explored such feature in three hippocampal areas, to verify 
whether electroacupuncture was able to counteract the diabetes-induced effects. We evaluated by stereological 
Figure 1. Electroacupuncture partially rescues diabetes-induced hippocampal cell loss. (A) Study design.  
(B) Blood glucose and (C) body weight measured 1 and 4 weeks after STZ treatment (mean ± SEM; n = 25 for 
each group). Repeated measures two-way ANOVA followed by Bonferroni multiple comparisons (P values 
shown in figure). (D) Representative picture of the dentate gyrus after Hoechst nuclear staining. Boxes highlight 
the regions were the analysis, shown in panels E–G, was performed. (E–G) Quantitative stereological analysis 
of the total number of cells and nuclear morphometric analysis in the dentate gyrus (DG; hilus and granular 
layer) and CA3 pyramidal layer of the rostral septal region of the hippocampus. In the upper part of the panels, 
representative pictures for each of the experimental groups. In the lower part of the panels, graphs depicting the 
results of the cell count and nuclear size analysis (means ± SEM of the estimated total cell number, n = 4 animals 
for each experimental group). One-way ANOVA followed by Bonferroni multiple comparisons (P values shown 
in figure).
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analysis the total number of cells in the granular layer (GL) and hilus (HL) of the DG and in the CA3-pyramidal 
cell layer (PCL) (Supplementary Fig. S1A,B), counting Hoechst-labelled nuclei (Fig. 1D–G). STZ overall reduced 
the number of total cells (Fig. 1E–G), which recovered after electroacupuncture treatment. Reduced number of 
Hoechst-labelled nuclei was accompanied by alterations in nuclear shape and staining texture, a common feature 
in all considered regions. The highly compact GL structure was looser in diabetic rats compared to controls, with 
surviving cells displaying particularly enlarged nuclei (Fig. 1E–G). Mean nuclear size returned to control levels 
after electroacupuncture treatment (Fig. 1E–G).
To assess whether the observed changes in hippocampal total cell number could reflect similar changes in 
neurons, we counted the number of NeuN+ and NeuN− cells in all three areas (Supplementary Fig. S1A,B). The 
number of neurons (NeuN+) in the GL decreased after streptozotocin and recovered in the STZ+ EA group 
(Supplementary Fig. S1C,D). The number of NeuN− cells decreased in the GL in both the STZ and STZ+EA 
groups (Supplementary Fig. S1C,D). In the HL, both NeuN+ and NeuN− cell number was lower in the STZ 
group compared to controls (Supplementary Fig. S1C,E), with only the number of NeuN− cells recovering in 
the STZ+EA group. In the PCL, NeuN+ and NeuN− cell number decreased after streptozotocin (Supplementary 
Fig. S1F,G) and only the number of NeuN+ cells normalized after electroacupuncture. Thus, the hippocampus 
was overall affected by cell loss, particularly neurons, in the DG and CA3 areas, at an early stage of diabetes 
development. This could be the result of increased apoptosis, as indirectly indicated by nuclear morphology, 
Figure 2. Electroacupuncture improves diabetes-induced impairments in memory, LTP and glutamatergic 
transmission in the dentate gyrus. (A–E) Effects of electroacupuncture (EA) treatment in diabetic animals (STZ) 
tested in the Morris Water Maze. Latencies to reach the platform in Place 1 (A) and Place 2 (C) and distances 
swam in the previously rewarded (platform) quadrant in Short-Term Probe 1 (Probe ST1; B), in Short-Term 
Probe 2 (Probe ST2; D), and in Long-Term Probe (Probe LT; E) are depicted (means ± SEM; n = 7 for each 
experimental group). Repeated measures two-way ANOVA followed by Bonferroni multiple comparison test 
(P values shown in figure). (F–G) Long-term potentiation at perforant-pathway (DG-LTP) in absence (F) or 
presence (G) of the muscarinic agonist Carbachol (CCh) in the superfusion bath. Field excitatory postsynaptic 
potentials (fEPSP) were recorded and expressed as the percentage of the pre-tetanus baseline. Changes in fEPSP 
slopes before and 60 min after the induction of LTP by high-frequency stimulation (HFS) of the medial perforant 
pathway (black arrow) are shown (means ± SEM; n = 8 for each experimental group). The insets represent 
typical fEPSP recordings; calibration bars: 0.5 mV, 10 ms. The average of DG-LTP magnitude 50–60 min after 
HFS is presented on the right side of the panels (median ± interquartile range, whiskers: min. and max.). One-
way ANOVA and Bonferroni multiple comparison (P values shown in figure). (H) Representative images of 
vGlut1 immunolocalization in the dentate gyrus of control (ctr), STZ and STZ+EA treated rats. Abbreviations: 
ML-molecular layer, GL-granular layer, HL-hilus, PCL-pyramidal cell layer. (I) Mean pixel intensity of vGlut1 
immunofluorescence in the molecular layer, granular cell layer and hilus of the DG and the pyramidal cell layer 
of the CA3 area (means ± SEM; n = 8 fields, 4 animals for each experimental group). One-way ANOVA followed 
by Bonferroni multiple comparison test, P values shown in figure. The cartoon illustrates the hippocampal 
glutamatergic circuitry where immunofluorescence analysis was performed.
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and of decreased DG neurogenesis, as indicated by our preliminary evidences on the decrease of doublecortin 
(DCX)-stained cells in the diabetic DG (Supplementary Fig. S2A,B). The rescuing effects of electroacupunc-
ture were evident on cell morphology (i.e. nucleus size), on the total cell number and also on the number of 
DCX-expressing cells in the DG (Supplementary Fig. S2A,B).
Electroacupuncture improved diabetes-induced impairments in memory, LTP and vGlut1 con-
tent in the dentate gyrus. Electroacupuncture may improve hippocampus-related cognitive deficits20. We 
investigated, by the Morris water maze (MWM) the early diabetes-induced memory deficits and verified whether 
Figure 3. Diabetes and electroacupuncture treatment differentially modulate proNGF expression in the 
hippocampus. (A) Representative images of proNGF immunolocalization in the dentate gyrus (DG) of the 
hippocampus. Insets: Higher magnifications showing proNGF immunolocalization within DG granule cells. 
(B–D) Mean pixel intensity and the number of proNGF immunopositive (proNGF+) cells in different areas of 
the DG (means ± SEM; n = 8 fields, 4 animals for each experimental group). One-way ANOVA followed by 
Bonferroni multiple comparison, P values shown in figure. (E) Cartoon depicting the experimental procedures 
performed in superfusion experiments and the possible carbachol (CCh) action on proNGF release by 
hippocampal cells. (F) Representative Western blot (WB) illustrating the time-course of carbachol-stimulated 
release of the 50 kDa proNGF from hippocampal slices of streptozotocin-treated rats. (G) Carbachol-stimulated 
proNGF release from hippocampal slices. Densitometry analysis of the WB (cropped representatives shown 
in the upper side of the panel; full-length blots are shown in online Supplementary material) illustrates the 
differences in carbachol-stimulated proNGF release among the different experimental groups. Data are 
expressed as percentage of the respective baselines (median ± interquartile range, whiskers: min. and max.). 
Two-way ANOVA followed by Bonferroni multiple comparisons, P values shown in figure. (H) WB of 
hippocampus superfusates after NGF-immunoprecipitation, revealing the presence of a 25 and a faint 34 kDa 
proNGF bands. (I) CCh-stimulated 25/34 kDa proNGF release from hippocampal slices measured by proNGF 
ELISA. Data (means ± SEM; n = 6 for each experimental group), represent the percentage of the respective 
baseline. Repeated-measure ANOVA followed by Bonferroni multiple comparison; P values shown in figure. 
Abbreviations: ML-molecular layer, GL-granular layer, HL-hilus, b-baseline, w/o-washout.
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electroacupuncture was able to counteract the eventual amnesic impairment. On day 1, in the Place 1, both STZ 
and STZ+EA groups showed higher latencies to reach the platform in comparison to controls (Fig. 2A; details 
on statistics at online Supplementary Table 2), indicating that streptozotocin administration induced a signif-
icant impairment not reversed by electroacupuncture. Consistently, in the short-term probe 1 phase, STZ and 
STZ+EA groups swam less than controls in the previously rewarded (platform) quadrant (Probe ST1; Fig. 2B). 
Otherwise, on day 2, in the Place 2, STZ group showed higher latencies in comparison to both ctr and STZ+EA 
groups (Fig. 2C; Supplementary Table 2), indicating that the streptozotocin-induced impairment was still pres-
ent in the second testing day. At this stage, STZ+EA group did not show significant amnesic impairment and 
exhibited latencies not different from those of the controls (Fig. 2C). In the Probe ST2, diabetic rats swam less in 
the previously rewarded quadrant in comparison to both ctr and STZ+EA groups (Fig. 2D). Finally, on day 3, 
in the long-term probe phase, STZ group continued to swim less in the previously rewarded quadrant (Fig. 2E). 
This finding indicated that the diabetes-induced memory impairment was still present at long term, although 
ameliorated compared to the previous day, so that the STZ group performance was not different by the one of the 
STZ+EA group (Fig. 2E). Once more, STZ+EA group showed a long-term memory performance not different 
by ctr group (Fig. 2E), indicating that electroacupuncture treatment succeeded in counteracting the impairing 
diabetes effects.
Synaptic plasticity and the hippocampal LTP are major cellular mechanisms underlying learning and memory23. 
We explored the possibility that diabetes may alter the excitatory circuits that drive the hippocampal func-
tions. DG-LTP data and their pairwise comparisons are summarized in Table 1. As reported24, the magnitude 
of DG-LTP was lowered by diabetes (Fig. 2F; Table 1). Notably, electroacupuncture fully restored DG-LTP in 
diabetic rats (Fig. 2F; Table 1), indicating that electroacupuncture rescuing effects on behavioural functions was 
associated with a recovery in hippocampal synaptic plasticity. As a first assessment on the role of muscarinic 
neurotransmission in our model, we evaluated long-term potentiation at dentate gyrus (DG-LTP) in the presence 
of the muscarinic agonist carbachol (100 nM; Fig. 2G), that is known to facilitate excitatory neurotransmission 
in the hippocampus25. Carbachol enhanced the DG-LTP in control rats (Table 1, row 2 vs row 1). Application of 
carbachol slightly ameliorated the diabetes-induced decrease in DG-LTP (Table 1, row 2 vs row 1). Surprisingly, 
the presence of carbachol, in the superfusion bath, diminished DG-LTP in the STZ+EA group (Table 1, row 
2 vs row 1), which was not different from the one measured in the STZ group (Fig. 2G; Table 1, row 2). These 
findings suggest that in diabetic rats the electroacupuncture effects on hippocampal synaptic plasticity relies on 
muscarinic receptor functions.
We also studied whether functional changes in the DG excitatory transmission were associated with altera-
tions in tissue distribution of a major marker of glutamatergic transmission, the vesicular glutamate transporter-1 
(vGlut1; Fig. 2H,I). Hippocampal content and distribution of vGlut1 was affected by both diabetes and electroac-
upuncture (Fig. 2H,I). vGlut1 immunolabeling in the ML and in the HL of STZ and STZ+EA groups (Fig. 2H) 
appeared as a diffuse staining, when compared to controls, that display a specific vGlut1 staining clustered at cell 
bodies. Protein expression levels were estimated by the mean pixel intensity of the vGlut1 immunofluorescence. 
After streptozotocin, vGlut1 mean pixel intensity did not vary in the GL, but decreased in all of the other hip-
pocampal regions (Fig. 2I). After electroacupuncture, values either returned to control levels (ML, HL and PCL) 
or became higher than controls (GL: Fig. 2I). Overall, the confocal microscopy analysis on vGlut1 suggested a 
decrease in the glutamate transport in diabetic rats that partially recovered after EA treatment.
proNGF expression was modified by diabetes and electroacupuncture, and modulated by mus-
carinic receptors activity. As the following, we studied proNGF distribution in the DG of control and 
treated rats. Figure 3A displays representative images of hippocampal slices immunolabeled for proNGF. The 
Table 1. Summary of DG-LTP data presented in Fig. 2, 4, 5 and pairwise comparisons between different 
groups. Data, presented as mean ± S.E.M., are percentage increase in fEPSP amplitude, having set the pre-
tetanus baseline at 100%. Statistics: Intra-experiment: One-way ANOVA followed by Bonferroni multiple 
comparison test. *P < 0.05 vs controls; §P < 0.05 vs STZ (comparisons within the same row). Inter-experiment 
1: Unpaired t-test. #P < 0.05 +carbachol vs −carbachol in the same experimental group (comparisons: row 2 vs 
row 1; row 4 vs row 3; row 6 vs row 5). Inter-experiment 2: Unpaired t-test. †P < 0.05 +antagonist vs -antagonist 
(baseline) in the same experimental group (comparisons: row 3 vs row 1; row 5 vs row 1; row 4 vs row 2; row 6 
vs row 2). n = 8 indicates the number rats. One hippocampal slice per animal was used for recordings.
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Figure 4. M1AChR tissue content and distribution is modified by diabetes and electroacupuncture and 
influences LTP and proNGF secretion. (A) Representative images of M1AChR immunolocalization in the 
dentate gyrus (DG). Insets: High-magnification details of M1AChR cellular distribution. (B–D) Mean 
pixel intensity and number of M1AChR immunopositive (M1AChR+) cells in different areas of the DG. 
Means ± SEM (n = 8 fields, 4 animals for each experimental group). One-way ANOVA followed by Bonferroni 
multiple comparison test, P values shown in figure. (E,F) Long-term potentiation at dentate gyrus (DG-LTP) 
after stimulation of hippocampal slices with the M1AChR selective antagonist telenzepine (TZ) and the non-
specific muscarinic agonist carbachol (CCh). Field excitatory postsynaptic potentials (fEPSP) were recorded 
and expressed as the percentage of the pre-tetanus baseline. Changes in fEPSP slopes before and 60 min after 
the induction of LTP by high-frequency stimulation (HFS) of the medial perforant pathway (black arrow) 
are shown (means ± SEM; n = 8 for each experimental group). The insets represent typical fEPSP recordings; 
calibration bars: 0.5 mV, 10 ms. The average of DG-LTP magnitude 50–60 min after HFS is presented on 
the right side of the panels (median ± interquartile range, whiskers: min. and max.). One-way ANOVA and 
Bonferroni multiple comparison (P values shown in figure). (G) Carbachol-stimulated proNGF release from 
hippocampal slices. Telenzepine was added to the superfusion bath before hippocampal slices were exposed to 
carbachol. Densitometry of the Western blots (cropped representatives shown in the upper side of the panel; 
full-length blots are shown in online Supplementary material) illustrates the differences in the telenzepine/
carbachol-stimulated proNGF release among the three experimental groups. Data are expressed as percentage 
of the respective baselines (median ± interquartile range, whiskers: min. and max.; n = 6 for each experimental 
group). Repeated-measure ANOVA followed by Bonferroni multiple comparison; P values shown in figure. 
(H) Carbachol-stimulated 25/34 kDa proNGF release from hippocampal slices measured by proNGF ELISA. 
Telenzepine was added to the superfusion bath before hippocampal slices were exposed to carbachol. Data, 
representing the percentage of the respective baseline means, are expressed as means ± SEM (n = 6 for each 
experimental group). Repeated-measure ANOVA followed by Bonferroni multiple comparison; P values shown 
in figure. Abbreviations: ML-molecular layer, GL-granular layer, HL-hilus, b-baseline, w/o-washout.
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Figure 5. Diabetes- and electroacupuncture-modified M2AChR expression and its influence on LTP and 
proNGF secretion. (A) Representative images of M2AChR immunolocalization in the dentate gyrus (DG) 
of the hippocampus. (B–D) Mean pixel intensity of M2AChR immunostaining in different areas of the DG 
and number of M2AChR immunopositive (M2AChR+) cells in the hilus. No immune-positive cells were 
detected in the granular layer (GL). Means ± SEM (n = 8 fields, 4 animals for each experimental group). One-
way ANOVA followed by Bonferroni multiple comparison test, P values shown in figure. (E,F) Long-term 
potentiation at DG (DG-LTP) after stimulation of hippocampal slices with the M2AChR selective antagonist 
AF-DX116 and the nonselective muscarinic agonist carbachol (CCh). Field excitatory postsynaptic potentials 
(fEPSP) were recorded and expressed as the percentage of the pre-tetanus baseline. Changes in fEPSP slopes 
before and 60 min after the induction of LTP by high-frequency stimulation (HFS) of the medial perforant 
pathway (black arrow) are shown (means ± SEM; n = 8 for each experimental group). The insets represent 
typical fEPSP recordings; calibration bars: 0.5 mV, 10 ms. The average of DG-LTP magnitude 50–60 min after 
HFS is presented on the right side of the panels (median ± interquartile range, whiskers: min. and max.). 
One-way ANOVA and Bonferroni multiple comparison, P values shown in figure. (G) Carbachol-stimulated 
proNGF release from hippocampal slices. AF-DX116 was added to the superfusion bath before hippocampal 
slices were exposed to carbachol. Densitometry of the Western blots (cropped representatives shown in the 
upper side of the panel; full-length blots are shown in online Supplementary material) illustrates the differences 
in AF-DX116/carbachol-stimulated proNGF release among experimental groups. Data are the percentage 
of respective baselines (median ± interquartile range, whiskers: min. and max.; n = 6 for each experimental 
group). Repeated-measure ANOVA followed by Bonferroni multiple comparison, P values shown in figure. 
(H) Carbachol-stimulated 25/34 kDa proNGF release from hippocampal slices measured by proNGF ELISA. 
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overall immunofluorescence intensity increased throughout the entire section in both STZ and STZ+EA groups, 
as shown by the heavy punctate immunolabeling sparse among the cells. Differently, intracellular immunola-
beling appeared to decrease, especially in the HL, after diabetes induction, followed by a slight recovery after 
electroacupuncture. Insets in each picture detail the distribution of the cellular immunolabeling in the GL: in 
the controls, proNGF immunofluorescence occurred in small puncta, mainly distributed within the cell bod-
ies. After streptozotocin, larger and more widespread clumps of immunoreactivity were evident, suggesting an 
increase in both the amount and size of proNGF secretory granules. Electroacupuncture after streptozotocin 
reduced the size of proNGF-positive (proNGF+) granules, indicating a switch toward control conditions. The 
pixel intensity of the proNGF immunolabeling was increased by diabetes in the ML (Fig. 3B) and GL (Fig. 3C), 
while it was not affected in the HL (Fig. 3D). Electroacupuncture further increased the mean pixel intensity in 
the ML (Fig. 3B) and GL (Fig. 3C). Conversely, the number of proNGF+ cells decreased after streptozotocin only 
in the HL (Fig. 3D), returning to control levels after electroacupuncture (Fig. 3D). These data indicate a possible 
diabetes-induced re-distribution of proNGF toward secretory compartments in both cell soma and dendritic 
terminals in the ML.
The production, release and extra-cellular processing of proNGF, in the hippocampus, is regulated by the 
BFCNs activity10. Thus, we turned out to a pharmacological stimulation of ex-vivo superfused hippocampus 
slices, to link the cholinergic input with the proNGF release and potential processing (Fig. 3E). A brief exposure 
of hippocampal slices to carbachol induced a transient increase in a 50 kDa proNGF isoform in the superfusion 
medium (Fig. 3F). When the hippocampus was exposed to carbachol, a little increase in the 50 kDa proNGF 
release was found in the control group, while a significant three-fold increase was observed in the STZ group 
(Fig. 3G). NGF-immunoprecipitation (Fig. 3H) revealed the presence, in the superfusion media, of a 34 kDa 
(faint) and a 25 kDa bands, most probably representing the proNGF-A and proNGF-B transcripts respectively26. 
Carbachol transiently increased the 25/34 kDa proNGF in the superfusates (Fig. 3I), in the controls. Carbachol 
stimulated a more robust and sustained proNGF release in the STZ group, that was absent in the STZ+EA group 
(Fig. 3I). Thus, the muscarinic challenge induced proNGF release from hippocampal slices that was modulated 
by electroacupuncture.
We also explored whether diabetes and electroacupuncture influenced the protease machinery responsible for 
the maturation and degradation of proNGF10. The carbachol-induced plasminogen and tissue plasminogen acti-
vator (tPA) release, from hippocampal slices, were increased in healthy animals (Supplementary Fig. S3), while 
no significant variations were found in both the STZ and STZ+EA groups. The activity of the matrix metallopro-
teinase (MMP)-2 and MMP-9 in the superfusates, as revealed by gelatine zymography (Supplementary Fig. S3), 
was increased in the STZ group and was normalized in the STZ+EA group. Thus, diabetes affected the extracel-
lular protease cascade mainly by increasing MMPs activity, while electroacupuncture counteracted the MMPs 
over-activity and modulated the muscarinic-regulated release of tPA, a factor upstream to MMPs in the protease 
activation cascade10. These data are consistent with an increased mNGF degradation (by MMPs) in diabetes that 
could shift toward a correct proNGF maturation and mNGF activity after electroacupuncture.
M1AChR modulated hippocampal functions after diabetes and electroacupuncture. Since 
proNGF release is under cholinergic control, we explored the role of the two main muscarinic acetylcholine 
(ACh) receptors expressed in the hippocampus, M1AChR and M2AChR, after diabetes induction and/or elec-
troacupuncture. In Fig. 4A, representative images show hippocampal sections immunolabeled for M1AChR. 
The faint punctate immunolabeling sparse among the cells, observed in the ctr group, increased in the STZ and 
STZ+EA groups. Differently, the intracellular immunolabeling in both HL and GL neurons decreased after dia-
betes induction and slightly recovered after electroacupuncture. An increased immunolabeling, as mean pixel 
intensity, was evident after streptozotocin, which however reached significance only in the ML (Fig. 4B–D). 
Electroacupuncture significantly enhanced the M1AChR immunostaining intensity in the ML (Fig. 4B–D). The 
number of M1AChR+ cells, in the GL and HL, decreased in the STZ group (Fig. 4C,D) and did not recover in 
GL after electroacupuncture (Fig. 4C). Thus, after diabetes induction, M1AChR increased and underwent tissue 
re-distribution, with a prevalent re-location of immunoreactivity toward the ML, while electroacupuncture fur-
ther increased M1AChR protein in the DG.
We, then, verified whether M1AChR participates in the regulation of both DG-LTP and proNGF release by 
hippocampal cells. To this aim, we used telenzepine (TZ), a selective M1AChR antagonist, both in basal condi-
tions and in the presence of carbachol. Bath-applied telenzepine (200 nM) lowered the magnitude of DG-LTP 
(Fig. 4E; statistics in Table 1), in hippocampal slices, from healthy rats (Table 1, row 3 vs row 1). Telenzepine did 
not affect DG-LTP in the STZ group, while it abolished the rescue of LTP (see Fig. 2F) in the STZ+EA group 
(Table 1 row 3 vs row 1), suggesting that M1AChR participates in the electroacupuncture-induced recovery of 
diabetes-impaired LTP.
Telenzepine counteracted the effects of carbachol on DG-LTP in healthy rats (Table 1, row 4 vs row 2), further 
confirming the LTP facilitation played by M1AChR. In the STZ group, carbachol together with telenzepine did 
not affect the magnitude of DG-LTP (Table 1 row 4 vs row 2). DG-LTP was depressed by carbachol and telenze-
pine, in the STZ+EA group (Fig. 4F; Table 1, row 4), suggesting a recovery of M1AChR activity after electroac-
upuncture. Furthermore, telenzepine exacerbated the carbachol-induced decrease in the magnitude of DG-LTP 
AF-DX116 was added to the superfusion bath before hippocampal slices were exposed to carbachol. Data 
are percentage of the respective baseline and are expressed as means ± SEM (n = 6 for each experimental 
group). Repeated-measure ANOVA followed by Bonferroni multiple comparison, P values shown in figure. 
Abbreviations: ML-molecular layer, GL-granular layer, HL-hilus, b-baseline, w/o-washout.
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observed in the STZ+EA group (Table 1, row 4 vs row 2), indicating that electroacupuncture probably acts also 
on the muscarinic LTP-depressive component27.
Telenzepine did not affect the carbachol-stimulated release of the 50 kDa proNGF from hippocampal slices 
(Fig. 4G), in all of the experimental groups. The 25/34 kDa proNGF species in the superfusion media, measured 
by proNGF ELISA (Fig. 4H), were also not significantly modulated by carbachol after telenzepine. Of note, tel-
enzepine pre-treatment inhibited the carbachol-induced increase in proNGF release (depicted at Fig. 3I), sug-
gesting a main role for M1AChR in regulating the proNGF secretion from brain cells. A significant interaction 
effect was observed for the two variables (antagonist/time and experimental group) in the two-way ANOVA 
(Supplementary Table 2), suggesting that the activity of M1AChR was different in different experimental groups. 
Indeed, the presence of telenzepine in the superfusion bath, further inhibited the carbachol-induced proNGF 
release from STZ+EA compared to STZ hippocampi, as confirmed by Bonferroni multiple comparison between 
the STZ and STZ+EA groups (not shown in Fig. 4H).
Role of M2AChR in modulating DG-LTP and proNGF release after diabetes and electroacupunc-
ture. We also evaluated the distribution and intensity of immunolabeling of the Gi/0-coupled M2AChR in the 
hippocampus. M2AChR-immunopositive fibres decorated the extracellular parenchyma in both ML and HL, 
living the GL largely unlabelled. After diabetes induction, the intensity of immunolabeling increased (Fig. 5A), 
as confirmed by the mean pixel intensity in the GL and HL (Fig. 5C,D). Electroacupuncture treatment, in dia-
betic rats, did not affect the intensity of immunolabeling but increased the number of M2AChR+ cells in the HL 
(Fig. 5D). This suggests that electroacupuncture was promoting a re-distribution of the M2AChR after it was 
increased by diabetes in the DG.
We evaluated the possible functional correlates of the M2AChR re-distribution by measuring basal and 
carbachol-stimulated DG-LTP and proNGF release in the presence of the M2AChR selective antagonist 
11-[[2-[(Diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one 
(AF-DX116)27. AF-DX116 potentiates basal DG-LTP in healthy rats (Table 1, row 5 vs row 1). In the presence of 
AF-DX116, DG-LTP was depressed in slices from the STZ group (Fig. 5E; Table 1, row 5) and recovered to control 
level in those from the STZ+EA group (Fig. 5E; Table 1, row 5). These data indicate that the M2AChR-mediated 
DG-LTP modulation is normally depressive and non-significantly affected by diabetes and electroacupuncture.
The simultaneous presence of AF-DX116 and carbachol (Fig. 5F) induced a little, but significant, potentia-
tion of DG-LTP in diabetic animals (Table 1, row 6 vs row 5), that was also noticed after carbachol administra-
tion alone (Table 1, row 6 vs row 2). In the STZ+EA group, the application of AF-DX116+carbachol depressed 
DG-LTP to STZ group levels (Fig. 5F; Table 1, row 6). This result confirms the apparent paradox effect of car-
bachol when applied to hippocampal slices from electroacupuncture-treated rats (Table 1, row 2 vs row 1). It 
suggests that the depression of LTP could be mediated by receptors other that M2AChR when an excess of ago-
nist is present, which could be either endogenous acetylcholine or exogenous carbachol27. Taken together with 
the M1AChR data, a picture emerges where electroacupuncture recovered the overall muscarinic facilitatory 
response.
We, then, evaluated the release of proNGF in the presence of AF-DX116. The basal release of the 50 kDa 
proNGF, from hippocampal slices, after AF-DX116 (Fig. 5G) increased in both ctr and STZ groups, and was not 
affected in the STZ+EA group, suggesting that the acetylcholine present in the brain parenchyma tonically inhib-
its proNGF release by challenging M2AChRs. The exposure of brain slices to AF-DX116+carbachol increased the 
50 kDa proNGF release in ctr and STZ+EA groups (Fig. 5G). AF-DX116 (before carbachol application) increased 
the 25/34 kDa proNGF in the superfusates in all of the experimental groups (Fig. 5H), further indicating that an 
M2AChR-mediated mechanism is active in controlling basal proNGF release, being probably not affected by both 
diabetes and electroacupuncture. Subsequent exposure of brain slices to carbachol, in the presence of AF-DX116, 
induced a transient proNGF release, which rapidly returned to baseline in ctr and STZ+EA groups, but remained 
higher than baseline for a longer time in the STZ group (Fig. 5H). The transient increase in proNGF release, in 
STZ group, was longer than the one shown in Fig. 3I, suggesting that the ability of M1AChR to stimulate proNGF 
secretion, selected by M2AChR blockade and carbachol challenge, was enhanced in diabetic brain and rescued 
by electroacupuncture.
Discussion
It is relevant that a major therapeutic approach to delay and/or attenuate the cognitive decline, in both Alzheimer’s 
disease and diabetic encephalopathy, relies on physical therapies28, 29. Here, we demonstrate that the diabetes 
development in young adult rats is characterized by mild-to-severe neuronal loss in the hippocampus; impair-
ment in hippocampal-related learning and memory; reduction in cellular glutamate trafficking and in synaptic 
plasticity; dysfunctions in the tissue distribution of muscarinic receptors; increased activity-dependent release of 
proNGF. Electroacupuncture, a physical therapy based on repetitive low-frequency sensory stimulation16, was 
able to counteract the early depressive effects of diabetes on the hippocampal neurotransmission and metabolism. 
Electroacupuncture, probably by rescuing the glutamate vesicular transport content and M1AChR-mediated cho-
linergic neurotransmission, normalized learning and memory functions and DG-LTP and regulated proNGF 
release in diabetic hippocampus. A schematic summary of the overall experimental findings is presented at Fig. 6.
The hippocampus is particularly vulnerable to both hyper- and hypoglycaemia2, 30. Our data on nuclear 
size and cell number indicate a possible general increase in transcription activity, confirming the apoptotic 
process activation in diabetic hippocampus31. The diabetes-induced cell loss encompassed both neuronal and 
non-neuronal cells, but the electroacupuncture rescuing effects appeared restricted to areas with high neuronal 
density (GL and PCL). Since electroacupuncture is a modulator of brain activity32 and neural plasticity33, 34, it is 
conceivable that excitatory granular and pyramidal neurons could benefit from the activation of sensory pro-
cesses, that stimulates the recovery of diabetes-impaired excitatory transmission and the normalization of the 
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muscarinic responsivity to cholinergic inputs. The stimulation delivered by electroacupuncture is known to mod-
ulate the peripheral and central processing of sensory information16, 32. The hippocampus integrates sensory infor-
mation driven from cortical areas and the midbrain and brainstem, these latter conveyed through BFCNs35, 36. 
Thus, electroacupuncture could affect hippocampal functions, by modulating both subcortical and cortical hip-
pocampal inputs.
The effects of diabetes and electroacupuncture were evident at the behavioural level. Diabetes induced a sig-
nificant decline in spatial learning and memory functions and, following electroacupuncture, the abilities of spa-
tial localization and memory reverted to control values. In the current experimental model of early diabetes, 
cognitive (spatial) deficits are present, similar to the dysfunctions in specific cognitive domains described in 
diabetic children and adolescents37. We demonstrate that they could benefit from electroacupuncture, which acts 
on specific functional and biochemical alterations in hippocampal regions. Our findings extend previous reports 
describing that nine weeks of hyperglycaemic pre-diabetic state are sufficient to generate mild cognitive impair-
ment38, while 40-day streptozotocin treatment combined to a cerebral ischemia produces consistent learning and 
memory deficits20. Such a cognitive impairment is positively affected by electroacupuncture treatment20.
We characterized the diabetes-induced re-distribution of major players involved in activity-dependent hip-
pocampal functions: vGlut1, M1AChR and M2AChR. vGlut1, a glutamate transporter preferentially associated 
with the membranes of synaptic vesicles and a specific molecular marker of vesicular glutamate release39. It has 
been suggested that vGlut1 has a functional role in hippocampal synaptic plasticity and in spatial learning and 
memory40. We found that vGlut1 was decreased in diabetic brain at sites where glutamatergic synapses partici-
pate in the propagation of excitatory signals from the cortex toward the hippocampus, namely ML, HL and PCL. 
Consistently, lower extracellular glutamate content at the DG of streptozotocin-treated rats has been previously 
reported41. The increase in the intracellular vGlut1 (at least in the HL) suggests that diabetes could selectively 
interfere with the traffic of glutamate toward efferent terminals, with a consequent decreased capability of diabetic 
hippocampus to generate LTP. Streptozotocin administration affected M1AChR and M2AChR in an opposite 
fashion in comparison to vGlut1. The suffering hippocampal neurons could undergo functional modifications24 
and structural derangement, i.e. dendritic tree alteration42. In diabetic rats, these modifications may result in 
M1AChR protein delocalization from neuron somata in the DG to their dendrites in the ML. Here is where 
the transmission of excitatory signal from the cortex to the DG physically occurs at axo-dendritic contacts and 
where the cholinergic fibres from the BFCN also exert their modulatory activity43. M2AChR immunolabeling 
Figure 6. Summary drawing of the experimental findings. The behavioural alteration found in the Morris 
water maze early after diabetes induction in young adult rats (upper part of the figure), were concomitant to 
the reduction in glutamatergic transmission (middle part of the figure), neuronal loss in the hippocampus, 
the depression of synaptic plasticity and the increased expression and possibly activity of the M1-subtype 
muscarinic receptor, resulting in increased activity dependent release of the proNGF (lower part of the figure). 
The electroacupuncture normalized spatial learning and memory performance in diabetic rats, improved 
glutamatergic neurotransmission, LTP and the activity-dependent release of proNGF, modulating the response 
of muscarinic receptor to acetylcholine challenge.
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also increased, but in different areas than M1AChR, namely the GL and HL, coherently with M2AChR main role 
as regulator of interneuron activities44. Thus, in the early diabetes, there could be an attempt of hippocampal cells 
to compensate the impairment of glutamatergic transmission by increasing cholinergic sensitivity. This attempt, 
instead of ameliorating the excitatory function, could in turn generate a potential harmful effect, mediated by the 
proNGF released upon muscarinic challenge10, 45.
Our data put together the impairment in LTP, the excess of proNGF and the muscarinic responsivity generated 
by diabetes in the hippocampus. The secretion of proNGF is regulated by glutamatergic and/or cholinergic neu-
rotransmission9, 45. It is conceivable that a M1AChR-mediated mechanism in the diabetic hippocampus is mostly 
responsible for the increase in proNGF tissue content6. Indeed, the reduction in glutamatergic transmission in 
the DG of diabetic rats was concomitant to an increased release of proNGF after muscarinic receptors challenge, 
an effect normalized by the M1AChR antagonist telenzepine. Considerably, the extracellular proNGF maturation 
and mNGF degradation10 was possibly shifted toward the latter (increased MMP9 activity in diabetic rats) that 
toward proNGF maturation (decrease of plasminogen and tPA in diabetic rats). proNGF accumulation, in dia-
betic hippocampus, could be involved in the regulation of neural plasticity and learning, directly influencing hip-
pocampal cells and circuitries and/or by modulating cholinergic transmission from the BFCN11, 46. While mature 
NGF positively affects LTP generation through TrkA46, the role of proNGF in regulating DG-LTP remains elusive. 
A mechanism based on its action on p75NTR deserves future in-depth analysis, in view of recent data demonstrat-
ing that proBDNF negatively regulates dendritic complexity and spines density and impairs hippocampal LTP by 
challenging p75NTR 47, and that proBDNF-p75NTR pathway is responsible for LTD-generated hippocampal synapse 
elimination48.
We hypothesized that electroacupuncture modulates hippocampal function trough the muscarinic activity. 
Both M1AChR and M2AChR positively regulate DG-LTP25, 27. M2AChR, acting as presynaptic auto-receptor, 
could also block the acetylcholine-mediated potentiation of LTP, by inhibiting acetylcholine release from cho-
linergic terminals49. The non-selective muscarinic agonist carbachol generated a large enhancement in DG-LTP 
in control but not in diabetic rats. Moreover, carbachol abolished the effects of electroacupuncture on diabetic 
hippocampi, leading the DG-LTP at levels comparable to those of the STZ group. This apparent paradox could be 
explained dissecting the respective roles of the muscarinic receptors. Telenzepine acted in similar ways in con-
trols and STZ+EA groups while it was almost ineffective on hippocampi from STZ group, suggesting that elec-
troacupuncture restores M1AChR modulation of DG-LTP. Conversely, blockade of M2AChR was ineffective in 
both STZ and STZ+EA groups. M2AChR located on interneurons inhibits GABA release, while on pre-synaptic 
cholinergic terminals it acts as inhibitory auto-receptor49. In our experiments, GABA-A receptors were blocked 
by picrotoxin to allow the measure of DG-LTP. Thus, the activity of AF-DX116 was restricted to the pre-synaptic 
M2AChRs and probably resulted in a facilitation of acetylcholine release by cholinergic terminals upon stimula-
tion of the perforant pathway. This response was lacking in diabetic animals, independently of electroacupuncture 
treatments, suggesting that electroacupuncture did not influence M2AChRs activity. It is conceivable, however, 
that electroacupuncture restores the acetylcholine tissue content, since the concomitant stimulation of the per-
forant pathway and the exposure to carbachol led to muscarinic agonist high dosage-dependent depression in 
fEPSP27. These described effects should be most probably mediated by receptors other than M2AChR and not 
related to the GABA ergic transmission27.
We found that M1AChR stimulated proNGF release, while M2AChR inhibited it. The abnormal release of 
proNGF in diabetic hippocampi, as well as its increased tissue content6, could reflect increased M1AChR and/
or reduced M2AChR activities. Electroacupuncture most probably normalizes this unbalance. Indeed, telenze-
pine depressed while AF-DX116 enhanced the carbachol-induced proNGF release, mainly in the STZ group; 
the STZ+EA group was instead found very similar to control. A muscarinic-mediated mechanism could be also 
responsible for the unbalance in the activity of the extracellular protease machinery responsible for proNGF 
maturation and mNGF degradation10, which shifted toward the latter in diabetic animals, probably contributing 
to the decrease in mNGF/proNGF balance in the diabetic brain6.
In conclusion, our data indicate that electroacupuncture in early diabetic rats, acts by favouring the 
maintenance of synaptic plasticity and its functional correlate (DG-LTP) in the hippocampus (Fig. 6). 
Electroacupuncture modulates both protein expression and hippocampal distribution of muscarinic receptors 
and of the neurotrophin proNGF, both involved in the regulation of hippocampal functions. It is conceivable that 
electroacupuncture action extends to the entire septo-hippocampal circuitry, also influencing the metabolism 
and functional properties of BFCNs. Overall, our findings point to the validity of physical therapies, such as 
electroacupuncture, as simple and effective interventions supportive of more complex and sometimes invasive 
pharmacological approaches targeting central neurons for the care of neurodegenerative diseases.
Methods
Detailed experimental procedures are described in the Supplementary material.
Animals. Fifty-day old female Sprague–Dawley rats were purchased from Harlan (Nossan, Italy). Rats were 
weighed and housed three per cage, with standard food and water available ad libitum. The animal room had a 
controlled 12-hours light cycle (lights on at 07:00 h), lux level (on average 100 lux), temperature (21 ± 1 °C) and 
relative humidity (50 ± 5%). All experiments were conducted according to the ARRIVE guidelines50. Animal care 
procedures were conducted in conformity with the Legislation for the protection of animals used for scientific 
purposes provided by the relevant Italian law and European Union Directive (Italian Legislative Decree 26/2014 
and 2010/63/EU) and the International Guiding Principles for Biomedical Research involving animals (Council 
for the International Organizations of Medical Sciences, Geneva, CH)51. Animals were subjected to experi-
mental protocols approved by the Veterinary Department of the Italian Ministry of Health (Permit Number: 
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192/2015–PR). All adequate measures were taken to minimize animal pain or discomfort and all surgery was 
performed under isoflurane anesthesia.
Diabetes induction and experimental design. Sixty-day old female Sprague-Dawley rats received a 
single intraperitoneal injection of 65 mg/kg Streptozotocin (STZ; cat. S0130, Sigma-Aldrich), dissolved in citrate 
buffer (vehicle), pH 4.522. One week after streptozotocin treatment, we analysed blood glucose and allocated rats 
with levels above 300 mg/dl to the diabetic groups. Rats were divided in three groups as follows: controls (ctr), 
once injected with vehicle; diabetics (STZ), treated with streptozotocin; electroacupuncture-treated diabetics 
(STZ+EA): electroacupuncture treatment was started one week after streptozotocin and performed twice a week 
for three weeks. Four weeks after streptozotocin, rats were either subjected to behavioural tests or euthanized and 
the whole brain or brain tissues collected for storage or immediate analysis.
Electroacupuncture. Stainless steel needles (diameter 0.20 mm) were inserted bilaterally at the traditional 
Chinese acupoints “Stomach 36” and “Large Intestine 4”5. Low-frequency electroacupuncture was given to con-
scious rats, placed in a soft fabric harness and suspended above the desk52, through a specific electrical stimulator 
(CEFAR ACU II; Cefar-Compex Scandinavia). The acupoints were electrically stimulated at 2 Hz frequency with 
0.1-sec, 80-Hz burst pulses. The intensity (0.8–1.0 mA) was monitored by checking for local muscle contractions, 
which reflect the activation of muscle-nerve afferents. Control and diabetic rats were exposed to the same han-
dling and suspension procedure, but not to electroacupuncture.
Behavioural testing in the Morris water maze. Seven rats/group were tested in the MWM apparatus, 
following a 3-day protocol. On day 1, each rat was submitted to 10-trial (120 s) Place 1 phase with the hidden 
platform put in the NW quadrant, followed by one trial (60 s) with no platform in the pool (Short-Term Probe 
1, Probe ST1). On day 2, the rat was submitted to 10-trial Place 2 phase with the hidden platform put in the SE 
quadrant, followed by one Probe trial (Short-Term Probe 2, Probe ST2). On day 3, the rat was submitted to one 
Probe trial (Long-Term Probe, Probe LT). MWM parameters considered were: latencies to reach the platform 
(Place 1 and Place 2); distance swum in the previously rewarded (platform) quadrant (Probe ST1, Probe ST2 and 
Probe LT).
Electrophysiology. For extracellular recordings, hippocampal slices (350 μM thick) were kept submerged 
at 30 °C and superfused (2–3 ml/min) with oxygenated (95% O2, 5% CO2) artificial CSF. Stimulation was applied 
to the medial perforant pathway of the dentate gyrus (DG), using a bipolar insulated tungsten wire electrode, 
and field excitatory postsynaptic potentials were recorded at a control test frequency of 0.033 Hz from the mid-
dle one-third of the molecular layer of the DG with a glass microelectrode. LTP was evoked by high-frequency 
stimulation (HFS) consisting of eight trains, each of eight stimuli at 200 Hz, and an inter-train interval of two 
seconds, with the stimulation voltage increased during the HFS protocol. Measurements of LTP were made 
60 min post-HFS. All solutions contained 50 μM picrotoxin (P1675, Sigma-Aldrich) to block GABA-A-mediated 
activity. The muscarinic modulation of LTP was investigated by carbachol (100 nM; cat. C4382, Sigma-Aldrich) 
stimulation of hippocampus slices. The specific role of muscarinic receptors subtypes was studied by telenze-
pine (200 nM; cat. T122, Sigma-Aldrich) and AF-DX116 (200 nM; cat. SML0435, Sigma-Aldrich), respectively 
M1AChR and M2AChR selective antagonists, applied in bath superfusion with or without carbachol.
proNGF release experiments. Hippocampal slices (350 µm thickness) were kept for 1h in cold oxygen-
ated artificial CSF. Slices were then placed into a superfusion system (Minucells and Minutissue), using 5.0 µm 
Durapore™ membrane filters (cat. SVLP01300, Millipore). The tissues were constantly superfused, at 37 °C and a 
flow rate of 0.25 ml/min, with modified Hank’s buffer pH 7.8, equilibrated with 95% O2 and 5% CO2. After 30 min, 
a sample of the superfusion buffer was collected representing the baseline and a 5 minutes-long stimulation with 
100 nM carbachol and/or with 200 nM telenzepine and/or with 200 nM AF-DX116 was applied, before returning 
to superfusion with modified Hank’s buffer. Samples were collected at 5 min intervals for 1h and immediately 
frozen at −80 °C.
Immunofluorescence, Stereology and Confocal Microscopy. Coronal 40 μm-thick brain sections 
were pre-incubated with PBS containing 10% (v/v) donkey serum, 1% (w/v) BSA and 0.3% (v/v) Triton X-100, 
for 2 h at room temperature (RT). Sections were then incubated, overnight (ON) at 4 °C, with primary antibodies 
diluted in the same medium (details at Supplementary Table 1). To assess for staining specificity, some of the 
sections were incubated in purified non-specific rabbit or mouse IgG. After washing with PBS, sections were 
incubated (2 h, RT) with specific secondary antibodies. Successively, sections were rinsed in PBS, incubated for 
10 min with Hoechst for nuclei staining.
For stereological analysis, cell counting was conducted using an Axioskop 2 (Zeiss) fluorescence microscope 
interfaced with the Stereo Investigator software package (MicroBrightField, v11). ROI (Supplementary Fig. 1A) 
were outlined using a 4x objective lens and cell counting was performed using the Optical Fractionator probe at 
a higher magnification (100x oil-immersion objective lens) according to the setup reported in Supplementary 
Fig. 1B.
For confocal microscopy analysis, sections were viewed at a confocal laser scanning microscope (SP5, Leica 
Microsystems) under sequential mode, to avoid crosstalk between channels. Confocal image acquisitions were 
conducted so that all samples were imaged using consistent settings for laser power and detector gain. Boundaries 
and subdivisions of the brain structures were identified with reference to the Paxinos’ Rat Brain atlas53. Image 
analysis was performed by the Imaris Suite 7.4 software (Bitplane A.G.). To evaluate the mean pixel intensity and 
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the number of cells in the different areas, a mask for each channel was manually drawn using the Imaris Surface 
module.
Immunoprecipitation. Superfusates (0.6 ml) were pre-cleared for 1h with protein A/G Sepharose 
(cat. 20421, Thermo Scientific) and then immune-precipitated, ON at 4 °C, with 2 µg of NGF H20 antibody 
(Supplementary Table 1) bound to 50 µl of protein A/G Sepharose beads. After incubation, protein A/G-bound 
immune-complexes were washed three times with PBS, then suspended in 50 µl of 2X reducing sample load-
ing buffer and boiled at 95–100 °C for 5 min to denature the protein and separate it from the Ab-protein A/G 
Sepharose bead complex. Sample were then processed for Western blot.
Western blot. Twenty milligrams protein samples were resolved by 8–12% SDS-PAGE as described5. Proteins 
were transferred onto nitrocellulose membrane by ON blotting at 30 V, then rinsed in T-PBS (PBS + 1% Tween 
20), blocked in T-PBS containing 5% non-fat dry milk and incubated, ON at 4 °C, with the primary antibod-
ies (Supplementary Table 1). The blotted membranes were then washed in T-PBS, incubated with horseradish 
peroxidase-labelled secondary antibody (Supplementary Table 1) and developed with the enhanced chemilumi-
nescence (ECL) detection system (WBKLS0500, Millipore). Gel densitometry was performed on scanned immu-
noblot images, using the ImageJ gel analysis tool. Full-lenght blots and loading controls corresponding to the 
cropped blots shown at Figs 3, 4 and 5 are depicted in Supplementary Fig. S4.
proNGF ELISA. The proNGF content in superfusates was measured by a recently developed specific ELISA6. 
The capture and detection antibodies (Supplementary Table 1) were chosen to detect selectively proNGF and to 
avoid cross-detection of mature NGF.
Statistical Analysis. Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software). 
Means were generally compared by one-way ANOVA and, unless mentioned otherwise (i.e. in Table 1), multi-
ple comparisons performed by Bonferroni post-hoc test. Differences were considered statistically significant if 
P < 0.05. When the measures for the main variable (three experimental groups) were repeated over time or after 
a pharmacologic treatment, means were analysed by two-way ANOVA with significance level = 0.05 (two-way 
ANOVA data at online Supplementary Table 2). Multiple comparisons by Bonferroni post-hoc test were then 
performed according to the main or interaction effects revealed by two-way ANOVA. Further details on Study 
design and statistics are given in online Supplementary methods.
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